Continuous regional arterial infusion for acute pancreatitis: A propensity score analysis using a nationwide administrative database

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Hamada, Tsuyoshi ^a   Yasunaga, Hideo ^b   Nakai, Yousuke ^a   Isayama, Hiroyuki ^a   Horiguchi, Hiromasa ^c   Matsuda, Shinya ^d   Fushimi, Kiyohide ^e   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIAPENEM; CARBAPENEM; DORIPENEM; GABEXATE MESILATE; IMIPENEM; MEROPENEM; NAFAMSTAT MESILATE; PANIPENEM; ANTIINFECTIVE AGENT; PROTEINASE INHIBITOR;

ACUTE PANCREATITIS; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; JAPANESE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL INFECTION; ACUTE DISEASE; DRUG COMBINATION; FACTUAL DATABASE; HOSPITAL COST; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; PANCREATITIS; PROPENSITY SCORE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; IMIPENEM; INFUSIONS, INTRA-ARTERIAL; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATITIS; PROPENSITY SCORE; PROTEASE INHIBITORS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84884788078     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13029     Document Type: Article

References (34)

1. Kingsnorth A, O'Reilly D. Acute pancreatitis. BMJ 2006, 332:1072-1076. 10.1136/bmj.332.7549.1072, 1458598, 16675814.
2. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008, 371:143-152. 10.1016/S0140-6736(08)60107-5, 18191686.
3. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, Skerrett SJ, Stapleton RD, Ware LB, Waldmann CS. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004, 32:2524-2536. 10.1097/01.CCM.0000148222.09869.92, 15599161.
4. Sekimoto M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Hirota M, Kimura Y, Takeda K, Isaji S, Koizumi M, Otsuki M, Matsuno S, JPN JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006, 13:10-24. 10.1007/s00534-005-1047-3, 2779368, 16463207, JPN.
5. Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 2000, 47:1147-1150.
6. Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004, 16:1287-1293. 10.1097/00042737-200412000-00009, 15618834.
7. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, Haapiainen R, Schröder T, Kivilaakso E. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995, 346:663-667. 10.1016/S0140-6736(95)92280-6, 7658819.
8. Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg 1998, 2:496-503. 10.1016/S1091-255X(98)80048-6, 10457308.
9. Yamauchi J, Takeda K, Shibuya K, Sunamura M, Matsuno S. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis: an experimental study using closed duodenal obstruction model in dogs. Pancreatology 2001, 1:662-667. 10.1159/000055878, 12120251.
10. Mikami Y, Takeda K, Matsuda K, Qiu-Feng H, Fukuyama S, Egawa S, Sunamura M, Matsuno S. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas 2005, 30:248-253. 10.1097/01.mpa.0000153328.54569.28, 15782103.
11. Takeda K, Matsuno S, Sunamura M, Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg 1996, 171:394-398. 10.1016/S0002-9610(97)89617-1, 8604829.
12. Takeda K, Matsuno S, Ogawa M, Watanabe S, Atomi Y. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. J Hepatobiliary Pancreat Surg 2001, 8:216-220. 10.1007/s005340170019, 11455482.
13. Imaizumi H, Kida M, Nishimaki H, Okuno J, Kataoka Y, Kida Y, Soma K, Saigenji K. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas 2004, 28:369-373. 10.1097/00006676-200405000-00003, 15097852.
14. Takeda K. Antiproteases in the treatment of acute necrotizing pancreatitis: continuous regional arterial infusion. JOP 2007, 8:526-532.
15. Ino Y, Arita Y, Akashi T, Kimura T, Igarashi H, Oono T, Furukawa M, Kawabe K, Ogoshi K, Ouchi J, Miyahara T, Takayanagi R, Ito T. Continuous regional arterial infusion therapy with gabexate mesilate for severe acute pancreatitis. World J Gastroenterol 2008, 14:6382-6387. 10.3748/wjg.14.6382, 2766122, 19009656.
16. Piascik M, Rydzewska G, Milewski J, Olszewski S, Furmanek M, Walecki J, Gabryelewicz A. The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study. Pancreas 2010, 39:863-867. 10.1097/MPA.0b013e3181d37239, 20431422.
17. Shanbhag ST, Petrov MS, Windsor JA. Is continuous regional arterial infusion of antiproteases now a standard of care in the treatment of acute pancreatitis?. Pancreas 2011, 40:1141.
18. Yasunaga H, Hashimoto H, Horiguchi H, Miyata H, Matsuda S. Variation in cancer surgical outcomes associated with physician and nurse staffing: a retrospective observational study using the Japanese Diagnosis Procedure Combination Database. BMC Health Serv Res 2012, 12:129. 10.1186/1472-6963-12-129, 3405470, 22640411.
19. Yasunaga H, Horiguchi H, Matsuda S, Fushimi K, Hashimoto H, Ohe K, Kokudo N. Relationship between hospital volume and operative mortality for liver resection: data from the Japanese diagnosis procedure combination database. Hepatol Res 2012, 42:1073-1080. 10.1111/j.1872-034X.2012.01022.x, 22548757.
20. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991, 74:81-86. 10.3171/jns.1991.74.1.0081, 1984512.
21. Ono K, Wada K, Takahara T, Shirotani T. Indications for computed tomography in patients with mild head injury. Neurol Med Chir (Tokyo) 2007, 47:291-298. 10.2176/nmc.47.291, 17652914.
22. Takeda K, Yokoe M, Takada T, Kataoka K, Yoshida M, Gabata T, Hirota M, Mayumi T, Kadoya M, Yamanouchi E, Hattori T, Sekimoto M, Amano H, Wada K, Kimura Y, Kiriyama S, Arata S, Takeyama Y, Hirota M, Hirata K, Shimosegawa T. Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. J Hepatobiliary Pancreat Sci 2010, 17:37-44. 10.1007/s00534-009-0213-4, 20012329.
23. Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, Singh VK, Slivka A, Whitcomb DC, Yadav D, Banks PA, Papachristou GI. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology 2012, 142:1476-1482. quiz e15-e16, 10.1053/j.gastro.2012.03.005, 22425589.
24. Hamada T, Yasunaga H, Nakai Y, Isayama H, Horiguchi H, Fushimi K, Koike K. Japanese severity score for acute pancreatitis well predicts in-hospital mortality: a nationwide survey of 17,901 cases. J Gastroenterol in press. doi:10.1007/s00535-013-0765-6.
25. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139. 10.1097/01.mlr.0000182534.19832.83, 16224307.
26. Singla A, Simons J, Li Y, Csikesz NG, Ng SC, Tseng JF, Shah SA. Admission volume determines outcome for patients with acute pancreatitis. Gastroenterology 2009, 137:1995-2001. 10.1053/j.gastro.2009.08.056, 19733570.
27. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999, 150:327-333. 10.1093/oxfordjournals.aje.a010011, 10453808.
28. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17:2265-2281. 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B, 9802183.
29. Rosenbaum PR, Rubin DB. Constructing a control-group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985, 39:33-38.
30. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 2008, 57:1698-1703. 10.1136/gut.2008.152702, 18519429.
31. Ueda T, Takeyama Y, Yasuda T, Kamei K, Satoi S, Sawa H, Shinzeki M, Ku Y, Kuroda Y, Ohyanagi H. Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis. J Gastroenterol 2009, 44:453-459. 10.1007/s00535-009-0026-x, 19308309.
32. Pezzilli R, Billi P, Morselli-Labate AM. Severity of acute pancreatitis: relationship with etiology, sex and age. Hepatogastroenterology 1998, 45:1859-1864.
33. Lankisch PG, Assmus C, Pflichthofer D, Struckmann K, Lehnick D. Which etiology causes the most severe acute pancreatitis?. Int J Pancreatol 1999, 26:55-57. 10.1007/BF02781731, 10597400.
34. Spanier BW, Dijkgraaf MG, Bruno MJ. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: an update. Best Pract Res Clin Gastroenterol 2008, 22:45-63. 10.1016/j.bpg.2007.10.007, 18206812.